Redmile Group, LLC Bristol Myers Squibb CO Transaction History

Redmile Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $29.5 Million - $33.5 Million	449,442 New	449,442 $31.2 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $83.6 Million - $121 Million	-1,800,800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $22.2 Million - $29 Million	-451,800 Reduced 20.06%	1,800,800 $116 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $24.9 Million - $29.6 Million	583,200 Added 34.93%	2,252,600 $114 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $3.11 Million - $3.44 Million	69,700 Added 4.36%	1,669,400 $75.7 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $33.6 Million - $40.1 Million	745,000 Added 87.17%	1,599,700 $76.3 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $41.7 Million - $54 Million	854,700 New	854,700 $44.4 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.